Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val
Hereditary transthyretin amyloidosis (ATTR) is an autosomal dominant rare disease caused by heterozygous mutations in the TTR gene, which encodes depolymerized transthyretin deposited in several organs. An induced pluripotent stem cell (iPSC) line of ATTR was generated from peripheral blood mononucl...
Main Authors: | He Shan, Jin Ye, Xing Hai Ping, He XinYue, Zhang ShuYang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506120302415 |
Similar Items
-
Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01) -
Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
by: Shan He, et al.
Published: (2020-12-01) -
Gastrointestinal disturbances in hereditary transthyretin amyloidosis
by: Wixner, Jonas
Published: (2014) -
Hereditary Transthyretin Amyloidosis in Eight Chinese Families
by: Ling-Chao Meng, et al.
Published: (2015-01-01) -
A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)